Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)
Blue Earth Therapeutics Ltd
Pathos AI, Inc.
National Institutes of Health Clinical Center (CC)
K36 Therapeutics, Inc.
M.D. Anderson Cancer Center
Varian, a Siemens Healthineers Company
M.D. Anderson Cancer Center
National Institutes of Health Clinical Center (CC)
University of California, Irvine
DL Analytics
RenJi Hospital
The Netherlands Cancer Institute
Queen Mary University of London
British Columbia Cancer Agency
The Netherlands Cancer Institute
Ottawa Hospital Research Institute
Marengo Therapeutics, Inc.
University of California, Irvine
Endocyte
Stanford University
Algemeen Ziekenhuis Maria Middelares
Regina Elena Cancer Institute
VA Greater Los Angeles Healthcare System
Mabwell (Shanghai) Bioscience Co., Ltd.
University of Toronto
Sheba Medical Center